{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:05Z","timestamp":1788995225199,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41401-026-01831-8","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:23:19Z","timestamp":1779423799000},"page":"2130-2143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FLRT2 promotes foam cell formation and atherosclerosis by inhibiting USP22-mediated ABCA1 deubiquitination"],"prefix":"10.1038","volume":"47","author":[{"given":"Jing-quan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-zhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-feng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-ye","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1831_CR1","first-page":"e41","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025;151:e41\u2013e660.","journal-title":"Circulation"},{"key":"1831_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9582430","volume":"2016","author":"YV Bobryshev","year":"2016","unstructured":"Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov AN. Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis. Biomed Res Int. 2016;2016:9582430.","journal-title":"Biomed Res Int"},{"key":"1831_CR3","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1161\/CIRCRESAHA.123.323156","volume":"134","author":"C Ma","year":"2024","unstructured":"Ma C, Li Y, Tian M, Deng Q, Qin X, Lu H, et al. Gs\u03b1 regulates macrophage foam cell formation during atherosclerosis. Circ Res. 2024;134:e34\u2013e51.","journal-title":"Circ Res"},{"key":"1831_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/geno.1999.6033","volume":"62","author":"SE Lacy","year":"1999","unstructured":"Lacy SE, B\u00f6nnemann CG, Buzney EA, Kunkel LM. Identification of FLRT1, FLRT2, and FLRT3: a novel family of transmembrane leucine-rich repeat proteins. Genomics. 1999;62:417\u201326.","journal-title":"Genomics"},{"key":"1831_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11184","volume":"7","author":"VA Jackson","year":"2016","unstructured":"Jackson VA, Mehmood S, Chavent M, Roversi P, Carrasquero M, Del Toro D, et al. Super-complexes of adhesion GPCRs and neural guidance receptors. Nat Commun. 2016;7:11184.","journal-title":"Nat Commun"},{"key":"1831_CR6","first-page":"2392","volume":"144","author":"I Tai-Nagara","year":"2017","unstructured":"Tai-Nagara I, Yoshikawa Y, Numata N, Ando T, Okabe K, Sugiura Y, et al. Placental labyrinth formation in mice requires endothelial FLRT2\/UNC5B signaling. Development. 2017;144:2392\u2013401.","journal-title":"Development"},{"key":"1831_CR7","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1038\/emboj.2011.189","volume":"30","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi S, Hampel F, Hata K, Del Toro D, Schwark M, Kvachnina E, et al. FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. EMBO J. 2011;30:2920\u201333.","journal-title":"EMBO J"},{"key":"1831_CR8","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1002\/jcb.23271","volume":"112","author":"Y Xu","year":"2011","unstructured":"Xu Y, Wei K, Kulyk W, Gong SG. FLRT2 promotes cellular proliferation and inhibits cell adhesion during chondrogenesis. J Cell Biochem. 2011;112:3440\u20138.","journal-title":"J Cell Biochem"},{"key":"1831_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1242\/dev.059386","volume":"138","author":"PS M\u00fcller","year":"2011","unstructured":"M\u00fcller PS, Schulz R, Maretto S, Costello I, Srinivas S, Bikoff E, et al. The fibronectin leucine-rich repeat transmembrane protein Flrt2 is required in the epicardium to promote heart morphogenesis. Development. 2011;138:1297\u2013308.","journal-title":"Development"},{"key":"1831_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neuron.2014.10.008","volume":"84","author":"E Seiradake","year":"2014","unstructured":"Seiradake E, del Toro D, Nagel D, Cop F, H\u00e4rtl R, Ruff T, et al. FLRT structure: balancing repulsion and cell adhesion in cortical and vascular development. Neuron. 2014;84:370\u201385.","journal-title":"Neuron"},{"key":"1831_CR11","first-page":"7350","volume":"41","author":"C Fleitas","year":"2021","unstructured":"Fleitas C, Marfull-Orom\u00ed P, Chauhan D, Del Toro D, Peguera B, Zammou B, et al. FLRT2 and FLRT3 cooperate in maintaining the tangential migratory streams of cortical interneurons during development. J Neurosci. 2021;41:7350\u201362.","journal-title":"J Neurosci"},{"key":"1831_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54570-x","volume":"15","author":"C Lla\u00f3-Cid","year":"2024","unstructured":"Lla\u00f3-Cid C, Peguera B, Kobialka P, Decker L, Vogenstahl J, Alivodej N, et al. Vascular FLRT2 regulates venous-mediated angiogenic expansion and CNS barriergenesis. Nat Commun. 2024;15:10372.","journal-title":"Nat Commun"},{"key":"1831_CR13","doi-asserted-by":"crossref","unstructured":"Hwang HJ, Kang D, Kim JR, Choi JH, Ryu JK, Herman AB, et al. FLRT2 prevents endothelial cell senescence and vascular aging by regulating the ITGB4\/mTORC2\/p53 signaling pathway. JCI Insight. 2024;9:e172678.","DOI":"10.1172\/jci.insight.172678"},{"key":"1831_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01520-x","volume":"15","author":"H Peng","year":"2023","unstructured":"Peng H, Palma-Gudiel H, Soriano-Tarraga C, Jimenez-Conde J, Zhang M, Zhang Y, et al. Epigenome-wide association study identifies novel genes associated with ischemic stroke. Clin Epigenetics. 2023;15:106.","journal-title":"Clin Epigenetics"},{"key":"1831_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162004","volume":"14","author":"Y Fang","year":"2023","unstructured":"Fang Y, Ma K, Huang YM, Dang Y, Liu Z, Xu Y, et al. Fibronectin leucine-rich transmembrane protein 2 drives monocyte differentiation into macrophages via the UNC5B-Akt\/mTOR axis. Front Immunol. 2023;14:1162004.","journal-title":"Front Immunol"},{"key":"1831_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624072","volume":"16","author":"S Seto","year":"2025","unstructured":"Seto S, Omori S, Nakamura H, Hijikata M, Keicho N. Single-cell transcriptomic profiling reveals a novel signature of necrotizing granulomatous lesions in the lungs of Mycobacterium tuberculosis-infected C3HeB\/FeJ mice. Front Immunol. 2025;16:1624072.","journal-title":"Front Immunol"},{"key":"1831_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol. 2022;19:228\u201349.","journal-title":"Nat Rev Cardiol"},{"key":"1831_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709\u201321.","journal-title":"Nat Rev Immunol"},{"key":"1831_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","volume":"71","author":"D Wang","year":"2019","unstructured":"Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung AWK, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71:596\u2013670.","journal-title":"Pharmacol Rev"},{"key":"1831_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118:653\u201367.","journal-title":"Circ Res"},{"key":"1831_CR21","doi-asserted-by":"publisher","first-page":"a2286","DOI":"10.1136\/bmj.a2286","volume":"337","author":"S Sathasivam","year":"2008","unstructured":"Sathasivam S, Lecky B. Statin induced myopathy. BMJ. 2008;337:a2286.","journal-title":"BMJ"},{"key":"1831_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"1831_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","volume":"124","author":"RA Hegele","year":"2019","unstructured":"Hegele RA, Tsimikas S. Lipid-lowering agents. Circ Res. 2019;124:386\u2013404.","journal-title":"Circ Res"},{"key":"1831_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tibs.2007.02.001","volume":"32","author":"AD Attie","year":"2007","unstructured":"Attie AD. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Trends Biochem Sci. 2007;32:172\u20139.","journal-title":"Trends Biochem Sci"},{"key":"1831_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/pr.119.017897","volume":"72","author":"S Frambach","year":"2020","unstructured":"Frambach S, de Haas R, Smeitink JAM, Rongen GA, Russel FGM, Schirris TJJ. Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment. Pharmacol Rev. 2020;72:152\u201390.","journal-title":"Pharmacol Rev"},{"key":"1831_CR26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40265-022-01743-x","volume":"82","author":"MJ Haas","year":"2022","unstructured":"Haas MJ, Mooradian AD. Potential therapeutic agents that target ATP binding cassette A1 (ABCA1) gene expression. Drugs. 2022;82:1055\u201375.","journal-title":"Drugs"},{"key":"1831_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1172\/JCI200423466","volume":"114","author":"P Pajukanta","year":"2004","unstructured":"Pajukanta P. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population? J Clin Invest. 2004;114:1244\u20137.","journal-title":"J Clin Invest"},{"key":"1831_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.nutr.26.061505.111214","volume":"26","author":"LR Brunham","year":"2006","unstructured":"Brunham LR, Singaraja RR, Hayden MR. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr. 2006;26:105\u201329.","journal-title":"Annu Rev Nutr"},{"key":"1831_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13:48\u201360.","journal-title":"Nat Rev Cardiol"},{"key":"1831_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.plipres.2017.12.001","volume":"69","author":"CPJ Talbot","year":"2018","unstructured":"Talbot CPJ, Plat J, Ritsch A, Mensink RP. Determinants of cholesterol efflux capacity in humans. Prog Lipid Res. 2018;69:21\u201332.","journal-title":"Prog Lipid Res"},{"key":"1831_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1152\/physrev.00005.2005","volume":"85","author":"JF Oram","year":"2005","unstructured":"Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85:1343\u201372.","journal-title":"Physiol Rev"},{"key":"1831_CR32","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/CIRCRESAHA.114.303974","volume":"114","author":"A Javaheri","year":"2014","unstructured":"Javaheri A, Rader DJ. Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified. Circ Res. 2014;114:1681\u20133.","journal-title":"Circ Res"},{"key":"1831_CR33","doi-asserted-by":"crossref","unstructured":"Cao L, Zhang J, Yu L, Yang W, Qi W, Ren R, et al. E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1. J Clin Invest. 2025;135:e186509.","DOI":"10.1172\/JCI186509"},{"key":"1831_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1191692","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J, Xu J, Chen C, Ma X, Zhu H, Xie L, et al. HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4+ T cell activation in Sjogren\u2019s syndrome. Front Pharmacol. 2023;14:1191692.","journal-title":"Front Pharmacol"},{"key":"1831_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbalip.2017.12.011","volume":"1863","author":"SM Aleidi","year":"2018","unstructured":"Aleidi SM, Yang A, Sharpe LJ, Rao G, Cochran BJ, Rye KA, et al. The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863:359\u201368.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1831_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62053-w","volume":"16","author":"M Loix","year":"2025","unstructured":"Loix M, Vanherle S, Bolkaerts L, Verberk SGS, Punt M, Wouters F, et al. UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation. Nat Commun. 2025;16:8077.","journal-title":"Nat Commun"},{"key":"1831_CR37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s42003-025-08116-6","volume":"8","author":"S Tang","year":"2025","unstructured":"Tang S, Lu C, Meng Z, Ye Z, Qin Y, Na N, et al. USP22 enhances atherosclerotic plaque stability and macrophage efferocytosis by stabilizing PPARgamma. Commun Biol. 2025;8:678.","journal-title":"Commun Biol"},{"key":"1831_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145164","volume":"318","author":"U Devi","year":"2025","unstructured":"Devi U, Shukla PK. The structural, functional, and regulatory insight of deubiquitinating enzyme - USP22. Int J Biol Macromol. 2025;318:145164.","journal-title":"Int J Biol Macromol"},{"key":"1831_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-024-01963-5","volume":"9","author":"Q Shan","year":"2024","unstructured":"Shan Q, Yin L, Zhan Q, Yu J, Pan S, Zhuo J, et al. The p-MYH9\/USP22\/HIF-1alpha axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Signal Transduct Target Ther. 2024;9:249.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01831-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:20:25Z","timestamp":1788992425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01831-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The human study was approved by the Medical Ethics Committee of the University of South China (USC202209HT17). Written informed consent was obtained from all participants or their legal representatives. All animal procedures were approved by the Institutional Animal Care and Use Committee of Guangzhou Medical University (Approval No. GY2019-016).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}